Close

gp160

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes the
acquired immunodeficiency syndrome (AIDS), a condition in humans in which progressive failure of
the immune system allows life-threatening opportunistic infections and cancers to thrive. Without
treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending
on the HIV subtype. Infection with HIV occurs by the transfer of blood, semen, vaginal fluid, preejaculate,
or breast milk. Within these bodily fluids, HIV is present as both free virus particles and
virus within infected immune cells.

Associated Disease
  • AIDS
  • CAR Vector Products

  • TCR Vector Products

  • TCR Viral Particles

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-T-2-LX354 Anti-HIV (ITS90.03) h(CD28-CD3ζ) CAR, pCDCAR1 Human ITS90.03 Macaque scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-T-2-LX419 Anti-HIV (ITS90.03) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human ITS90.03 Macaque scFv-4-1BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-T-2-LX660 Anti-HIV (ITS90.03) (CD4-scFv-h(CD28-CD3ζ)) CAR, pCDCAR1 Human ITS90.03 Macaque CD4-scFv-CD28-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
CAR-T-2-LX901 Anti-HIV (ITS90.03) (CD4-scFv-h(4-1BB-CD3ζ)) CAR, pCDCAR1 Human ITS90.03 Macaque CD4-scFv-4-1BB-CD3ζ Lentiviral vector T cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.